HY-100009-10mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
HY-100009-100mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
HY-100009-5mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
HY-100009-50mg
|
MedChemexpress LLC
|
Ufenamate [CAS 67330-25-0]
|
|
COVID-19-immunoregulation
|
|
HY-10002-1mg
|
MedChemexpress LLC
|
Calcitriol [CAS 32222-06-3]
|
|
COVID-19-immunoregulation
|
|
HY-10002-10mg
|
MedChemexpress LLC
|
Calcitriol [CAS 32222-06-3]
|
|
COVID-19-immunoregulation
|
|
HY-10002-100mg
|
MedChemexpress LLC
|
Calcitriol [CAS 32222-06-3]
|
|
COVID-19-immunoregulation
|
|
HY-10002-2mg
|
MedChemexpress LLC
|
Calcitriol [CAS 32222-06-3]
|
|
COVID-19-immunoregulation
|
|
HY-10002-5mg
|
MedChemexpress LLC
|
Calcitriol [CAS 32222-06-3]
|
|
COVID-19-immunoregulation
|
|
HY-10002-50mg
|
MedChemexpress LLC
|
Calcitriol [CAS 32222-06-3]
|
|
COVID-19-immunoregulation
|
|
HY-100085-1mg
|
MedChemexpress LLC
|
21-Desacetyldeflazacort [CAS 13649-57-5]
|
|
COVID-19-immunoregulation
|
|
HY-10011-10mg
|
MedChemexpress LLC
|
SCH 563705 [CAS 473728-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-10011-5mg
|
MedChemexpress LLC
|
SCH 563705 [CAS 473728-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-100113-10mg
|
MedChemexpress LLC
|
Buloxibutid [CAS 477775-14-7]
|
|
COVID-19-immunoregulation
|
|
HY-100113-100mg
|
MedChemexpress LLC
|
Buloxibutid [CAS 477775-14-7]
|
|
COVID-19-immunoregulation
|
|
HY-100113-25mg
|
MedChemexpress LLC
|
Buloxibutid [CAS 477775-14-7]
|
|
COVID-19-immunoregulation
|
|
HY-100113-5mg
|
MedChemexpress LLC
|
Buloxibutid [CAS 477775-14-7]
|
|
COVID-19-immunoregulation
|
|
HY-100113-50mg
|
MedChemexpress LLC
|
Buloxibutid [CAS 477775-14-7]
|
|
COVID-19-immunoregulation
|
|
HY-100131-10mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-100131-100mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-100131-2mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-100131-5mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-100131-50mg
|
MedChemexpress LLC
|
GSK481 [CAS 1622849-58-4]
|
|
COVID-19-immunoregulation
|
|
HY-10015-10mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|
HY-10015-100mg
|
MedChemexpress LLC
|
PAP-1 [CAS 870653-45-5]
|
|
COVID-19-immunoregulation
|
|